IPCA LABORATORIES LTD (524494) — Latest Corporate Announcements
₹1,899.3
₹-0.60 (-0.03%)
Market Cap
₹48,186.05 Cr
P/E Ratio
36.49
52W Range
₹1251.6 – ₹2038
Corporate Actions & Regulatory Filings
IPCA Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Ipca Laboratories Ltd - 524494 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Ipca Laboratories Ltd - 524494 - Closure of Trading Window
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended December 31, 2025
To consider and approve the financial results for the period ended September 30, 2025
To consider and approve the financial results for the period ended Jun 30, 2025
To consider and approve the financial results for the period ended March 31, 2025 and Final dividend
To consider and approve the financial results for the period ended December 31, 2024
To consider and approve the Standalone and Consolidated financial results for the period ended September 30, 2024 and Interim dividend
To consider and approve the financial results for the period ended Jun 30, 2024
To consider and approve the financial results for the period ended March 31, 2024 and dividend
To consider and approve the financial results for the period ended December 31, 2023
To consider and approve the financial results for the period ended September 30, 2023 and dividend
To consider and approve the financial results for the period ended Jun 30, 2023
To consider and approve the financial results for the 4th quarter and financial year ended March 31, 2023
To consider and approve the financial results for the period ended December 31, 2022
IPCA Laboratories Limited has informed the Exchange about Board Meeting to be held on 10-Aug-2022 to consider financial statements for the period ended June 2022
To consider and approve the financial results for the period ended December 31, 2021
Financial Results (Quarterly & Annual)
| Quarter / Period | Meeting / Outcome Date | Status | Filing Details |
|---|---|---|---|
| Quarter Ended 30-Jun-2026 (Q1 FY27) | 13-Aug-2026 | Declared | To consider and approve the financial results for the period ended Jun 30, 2026 |
| Year Ended 31-Mar-2026 (Q4 FY26) | 29-May-2026 | Declared | To consider and approve the financial results for the period ended March 31, 2026 and dividend |
| Quarter Ended 31-Dec-2025 (Q3 FY26) | 13-Feb-2026 | Declared | To consider and approve the financial results for the period ended December 31, 2025 |
| Quarter Ended 30-Sep-2025 (Q2 FY26) | 13-Nov-2025 | Declared | To consider and approve the financial results for the period ended September 30, 2025 |
| Quarter Ended 30-Jun-2025 (Q1 FY26) | 11-Aug-2025 | Declared | To consider and approve the financial results for the period ended Jun 30, 2025 |
| Year Ended 31-Mar-2025 (Q4 FY25) | 29-May-2025 | Declared | To consider and approve the financial results for the period ended March 31, 2025 and Final dividend |
| Quarter Ended 31-Dec-2024 (Q3 FY25) | 13-Feb-2025 | Declared | To consider and approve the financial results for the period ended December 31, 2024 |
| Quarter Ended 30-Sep-2024 (Q2 FY25) (STD & CONSOL) | 14-Nov-2024 | Declared | To consider and approve the Standalone and Consolidated financial results for the period ended September 30, 2024 and Interim dividend |
| Quarter Ended 30-Jun-2024 (Q1 FY25) | 13-Aug-2024 | Declared | To consider and approve the financial results for the period ended Jun 30, 2024 |
| Year Ended 31-Mar-2024 (Q4 FY24) | 29-May-2024 | Declared | To consider and approve the financial results for the period ended March 31, 2024 and dividend |
| Quarter Ended 31-Dec-2023 (Q3 FY24) | 14-Feb-2024 | Declared | To consider and approve the financial results for the period ended December 31, 2023 |
| Quarter Ended 30-Sep-2023 (Q2 FY24) | 10-Nov-2023 | Declared | To consider and approve the financial results for the period ended September 30, 2023 and dividend |
Track Related Peer Equities
Related Research Guides & Regulatory Playbooks
Frequently Asked Questions about IPCA LABORATORIES LTD BSE Disclosures
What is the latest BSE announcement by IPCA LABORATORIES LTD?
The latest BSE disclosure by IPCA LABORATORIES LTD (IPCALAB), filed on 12-Oct-2026 15:26:47, is: "IPCA Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018". Bsenexus tracks every official filing for IPCA LABORATORIES LTD with AI-powered summaries on its announcements feed.
When is IPCA LABORATORIES LTD's next board meeting?
No upcoming board meeting is currently tracked for IPCA LABORATORIES LTD. Companies disclose meeting intimations under SEBI LODR, and scheduled dates appear on the Bsenexus Results Calendar.
When does IPCA LABORATORIES LTD declare quarterly results?
Under SEBI (LODR) Regulation 33, listed companies submit quarterly unaudited results within 45 days of the quarter ending, and annual audited figures within 60 days. IPCA LABORATORIES LTD's recent results history is tabulated above. Track scheduled board meetings on the Bsenexus Results Calendar.